ALB ALBEMARLE CORP

ALB financial statements, revenue, balance sheet, cash flow, and SEC filings

CIK: 915913 Exchange: NYSE SIC: 2821 (Plastic Materials, Synth Resins & Nonvulcan Elastomers) Latest filing: 10-Q filed Aug 5, 2026 Data checked: Oct 21, 2026
Showing 3 of 18 annual and 0 of 68 quarterly periods. Full history available with a free account or via API.

▼ Company Profile

Filer Category
Large accelerated filer
Entity Type
Operating
Public Float
$7.40B (Jun 2025)
Industry (SIC)
2821 Plastic Materials, Synth Resins & Nonvulcan Elastomers
Incorporated
VA
Fiscal Year End
December (1231)
Phone
980-299-5700
EIN
541692118
Headquarters
CHARLOTTE, NC, 28209
Public Float History
Market value of shares held by public investors, reported in annual DEI filings.

▼ Key Metrics (TTM)

As of Jun 30, 2026
Financials
Revenue
$5.91B
Net Income
$224.18M
Total Assets
$15.91B
Total Equity
$10.53B
Total Debt
$1.88B
Free Cash Flow
$1.34B
Ratios
Gross Margin
23.8%
Operating Margin
4.3%
Net Margin
3.8%
Return on Equity
2.1%
Return on Assets
1.4%
Current Ratio
2.09x
Debt / Equity
0.18x
FCF / Assets
8.4%

▼ FY 2025 Summary Analysis

Annual report ending Dec 31, 2025

Overview and Growth

In fiscal 2025, ALBEMARLE CORP recorded $5.14B of revenue, net loss of $510.63M, and an operating cash inflow of $1.28B. At $5.14B, the top line establishes the operating scale supporting the company’s profit and cash-flow profile. Revenue was 4.4% below fiscal 2024 revenue of $5.38B, marking a top-line contraction. On a per-share basis, diluted EPS was -$5.76, which connects the reported earnings outcome with the company’s diluted share count. Total assets stood at $16.37B, showing the scale of resources supporting revenue, earnings, liquidity, and financing. Revenue equaled 0.31x of total assets, indicating how much reported top-line activity the company produced relative to its period-end asset base.

Profitability

After reported cost of revenue, the company retained $668.72M as gross profit before recognizing operating expenses and other items. Gross profit represented 13.0% of revenue, showing how much of the top line remained after direct costs. Operations produced a $367.08M operating loss before non-operating and tax effects. An operating margin of -7.1% reflected costs exceeding revenue-level gross profit by 7.1% of sales. After all below-operating-line items, the company recorded a net loss of $510.63M for the fiscal year. Measured against revenue, the bottom-line deficit represented 9.9% after all recognized items. The reported income-tax provision was $156.88M, the amount recognized between pretax income and the final net-income result. The net loss equaled 5.2% of period-end equity, showing the deficit relative to book capital. The loss-to-assets relationship was 3.1%, placing the bottom-line deficit against the company’s resource base. Compared with a $1.18B net loss in fiscal 2024, the current loss improved to $510.63M.

Liquidity and Capital Structure

The company held $16.37B of assets against $6.59B of liabilities and $9.78B of equity, revealing how the asset base was financed. Current assets were $4.01B against $1.80B of current liabilities, framing the resources and obligations classified within the near-term balance-sheet horizon. At 2.23x, the current ratio shows that short-term assets were greater than short-term liabilities at period end. Reported cash and equivalents were $1.62B, separating immediately recognizable cash resources from the rest of the current-asset base. The cash balance equaled 90.0% of current liabilities, showing how much near-term coverage came from cash alone. The company carried $3.19B of total debt at period end, which frames its leverage and debt-service burden. The debt-to-equity relationship was 0.33x, showing how much debt the company carried for each unit of book equity. The debt-to-assets relationship was 19.5%, comparing borrowing with the total asset balance. Relative to total assets, liabilities measured 40.3%, complementing the separate equity-based view of the company’s capital structure. Measured against total assets, cash and equivalents represented 9.9%, a balance-sheet composition measure rather than a liquidity forecast. Compared with $16.61B in fiscal 2024, the current asset base moved 1.4% and finished lower. Reported equity changed 4.1% from $10.20B in fiscal 2024, placing the current capital base lower year over year. Cash and equivalents were 35.7% higher than fiscal 2024 cash of $1.19B, showing the year-over-year change in liquid resources.

Cash Flow and Earnings Quality

Operating activities produced a cash inflow of $1.28B, giving the cash-flow counterpart to the accrual-based profit measures reported for the year. The cash-flow statement records $589.80M of capital expenditures, the investment amount considered after operating cash generation. Capital expenditures represented 46.0% of operating cash flow, leaving the remainder available as free cash flow. Free cash flow came to $692.47M, leaving a positive amount after capital expenditures. Free cash flow represented 13.5% of revenue, linking post-investment cash generation with the company’s operating scale. Free cash flow equaled 4.2% of total assets, relating post-investment cash generation to the company’s resource base.
Based on the annual report for the fiscal year ending Dec 31, 2025. Analysis generated .
Sources and calculation details

Reported values are preserved. Derived values use the listed inputs; unavailable inputs remain blank.

Field-level sources for this historical record are unavailable until it is rebuilt from SEC facts.

Annual financial statements for ALBEMARLE CORP
Metric FY2025 📄 FY2024 📄 FY2023 📄
Income Statement
REVENUE
Revenue $5.14B $5.38B $9.62B
Cost of Revenue $4.47B $5.31B $8.43B
Gross Profit $668.72M $62.54M $1.19B
OPERATING EXPENSES
R&D Expense $51.40M $86.72M $85.73M
SG&A Expense $550.04M $618.05M $910.00M
Other Operating Expenses (derived) $434.37M $1.13B $-61.70M
Operating Income $-367.08M $-1.78B $251.88M
NON-OPERATING INCOME / EXPENSE
Interest Expense $207.65M $165.62M $116.07M
Other Income/Expense $22.66M $178.34M $110.93M
Income Tax $156.88M $87.09M $430.28M
Net Income $-510.63M $-1.18B $1.57B
PER SHARE & SUPPLEMENTAL
Diluted EPS $-5.76 $-11.20 $13.36
Diluted Shares 117.66M 117.52M 117.77M
EBITDA $291.59M $-1.19B $681.83M
Depreciation & Amortization $658.68M $588.64M $429.94M
Balance Sheet
ASSETS
Cash & Equivalents $1.62B $1.19B $889.90M
Accounts Receivable $593.50M $742.20M $1.21B
Inventory $1.18B $1.50B $2.16B
Other Current Assets $140.44M $166.92M $443.48M
Current Assets $4.01B $3.84B $5.22B
PP&E (Net) $8.61B $9.33B $9.50B
Goodwill $1.50B $1.58B $1.63B
Intangible Assets $214.23M $230.75M $261.86M
Other Noncurrent Assets $647.19M $504.71M $297.09M
Noncurrent Assets $12.37B $12.77B $13.05B
Total Assets $16.37B $16.61B $18.27B
LIABILITIES
Short-term Debt $74.08M $398.02M $625.76M
Other Current Liabilities $288.53M $308.73M $376.47M
Current Liabilities $1.80B $1.97B $3.56B
Long-term Debt $3.12B $3.12B $3.54B
Other Noncurrent Liabilities $1.08B $819.20M $769.10M
Noncurrent Liabilities $4.79B $4.44B $5.05B
Total Liabilities $6.59B $6.41B $8.61B
EQUITY
Common Stock $1.18M $1.18M $1.17M
Additional Paid-in Capital $3.02B $2.99B $2.95B
Retained Earnings $4.61B $5.48B $6.99B
Accumulated OCI $-334.81M $-742.06M $-528.53M
Total Equity $9.78B $10.20B $9.67B
Total Liabilities & Equity $16.37B $16.61B $18.27B
SUPPLEMENTAL
Total Debt $3.19B $3.52B $4.17B
Shares Outstanding 117.72M 117.56M 117.36M
Check: A − (L + E + Temp. Equity) - - -
Cash Flow Statement
Cash from Operations $1.28B $687.88M $1.33B
Capital Expenditures $589.80M $1.68B $2.15B
Cash from Investing $-146.01M $-1.58B $-2.56B
Cash from Financing $-834.19M $1.24B $623.91M
Free Cash Flow $692.47M $-992.65M $-827.96M
Beginning Cash (CFS) $1.19B $889.90M $1.50B
Net Change in Cash $302.07M $344.84M $-614.08M
Effect of FX on Cash $123.70M $-42.51M $4.84M
Calculated Ending Cash $1.62B $1.19B $889.90M
Cash per BS $1.62B $1.19B $889.90M
Cash scope difference (CFS − BS) - - -
Cash per CFS $1.62B $1.19B $889.90M

Create a free account to see full history, quarterly data, charts, CSV downloads, and API access.

Create Free Account Log In
🔒

Quarterly data and charts require a free account

Get access to 8 quarters of data, interactive charts, CSV downloads, and API access.

▼ Frequently Asked Questions

What is ALBEMARLE CORP's annual revenue?

ALBEMARLE CORP reported $5.91B in revenue for trailing twelve months (ending June 2026). Revenue figures are sourced from the company's annual SEC EDGAR filing.

Is ALBEMARLE CORP profitable?

Yes. ALBEMARLE CORP reported $224.18M in net income for trailing twelve months. Profitability data is based on the company's most recent annual report filed with the SEC.

What is ALBEMARLE CORP's debt level?

ALBEMARLE CORP carries $1.88B in total debt as of trailing twelve months. Total shareholders' equity stands at $10.53B.

Does ALBEMARLE CORP generate free cash flow?

Yes. Free cash flow was $1.34B for trailing twelve months. Operating cash flow was $1.80B.